Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Franklin, TN
NPI
1124226477
Since 2007
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
100 Covey Dr Ste 205
Franklin, TN, 37067
Phone (615) 284-4664
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
2,596 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$399K
2,230 prescriptions
Company payments, 2025
$360
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Tatalovich was code 99213 (office e&m - established), 268 times for 191 patients. In total Jennifer M Tatalovich billed 2,596 services in 52 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 268 | 191 | $53.51 | $14K |
| 99214 Office E&M - Established | Office | 256 | 193 | $88.64 | $23K |
| 81002 Clinical Chemistry | Office | 111 | 100 | $3.38 | $375 |
| 99204 Office E&M - New | Office | 98 | 98 | $108.04 | $11K |
| 99215 Office E&M - Established | Office | 51 | 45 | $129.73 | $6,616 |
| 51741 Test - Miscellaneous | Office | 32 | 31 | $5.27 | $169 |
| 51797 Other Organ Systems | Office | 31 | 30 | $133.87 | $4,150 |
| 51784 Neurologic | Office | 31 | 30 | $23.19 | $719 |
| 51729 Other Organ Systems | Office | 31 | 30 | $266.92 | $8,275 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 30 | 30 | $35.02 | $1,051 |
| 17250 Destruction Skin Lesion | Office | 23 | 12 | $60.39 | $1,389 |
| 99205 Office E&M - New | Office | 21 | 21 | $136.13 | $2,859 |
| 57425 Other Organ Systems | Facility | 20 | 20 | $695.63 | $14K |
| 99203 Office E&M - New | Office | 14 | 14 | $81.20 | $1,137 |
| 58571 Other Organ Systems | Facility | 11 | 11 | $388.30 | $4,271 |
By year: 2022 $103K for 3,267 services; 2023 $97K for 2,362 services; 2024 $113K for 2,596 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 111 | 100 | $3.38 | $375 |
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Tatalovich prescribed most often to Medicare patients was Estradiol, with 521 prescriptions and refills. In total Jennifer M Tatalovich wrote 2,230 Medicare prescriptions that cost $399K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 521 | 1,765 | 264 | $60K |
| Gemtesa Vibegron | 270 | 418 | 65 | $197K |
| Fluconazole Generic | 168 | 213 | 84 | $1,206 |
| Solifenacin Succinate Generic | 142 | 276 | 46 | $11K |
| Cephalexin Generic | 128 | 204 | 73 | $1,003 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 89 | 138 | 62 | $2,659 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 69 | 69 | 59 | $184 |
| Estradiol (Twice Weekly) Estradiol | 60 | 123 | 16 | $6,735 |
| Yuvafem Estradiol | 56 | 148 | 19 | $9,198 |
| Amitriptyline Hcl Generic | 54 | 128 | 16 | $786 |
| Ibuprofen Generic | 51 | 51 | 35 | $243 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 48 | 60 | Under 11 | $2,232 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 44 | 44 | 39 | $226 |
| Ciprofloxacin Hcl Generic | 42 | 42 | 32 | $160 |
| Methenamine Hippurate Generic | 42 | 104 | 15 | $5,335 |
Brand drugs: 444 claims; generic drugs: 1,786 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer M Tatalovich $360 ($360 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $129.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.